Flicking the molecular switch underlying MLKL-mediated necroptosis

Area of Science:

• Molecular biology
• Cell death pathways
• Biochemistry

Background:

• Mixed lineage kinase domain-like (MLKL) is a key effector in necroptosis, a regulated form of cell death.
• The pseudokinase domain of MLKL acts as an autoinhibitory mechanism, restraining the N-terminal 4-helix bundle (4HB) domain.
• Activation of MLKL involves the release of the 4HB domain, leading to membrane permeabilization and cell death.

Purpose of the Study:

• To elucidate the inhibitory mechanism of the MLKL pseudokinase domain.
• To investigate the role of the 4HB domain in MLKL-mediated cell death.
• To identify potential therapeutic targets for modulating necroptosis.

Main Methods:

• Structural analysis of the MLKL pseudokinase domain.
• Biochemical assays to study MLKL activation and inhibition.
• Cell-based assays to assess MLKL-mediated cell death.

Main Results:

• The pseudokinase domain of MLKL functions as a molecular latch, inhibiting the N-terminal 4HB domain.
• Membrane association and oligomerization of the 4HB domain are critical for MLKL-mediated cell death.
• An ATP-mimetic small molecule was identified that binds the pseudokinase domain and inhibits MLKL activity.

Conclusions:

• The pseudokinase domain is a crucial regulatory element of MLKL.
• Targeting the pseudokinase domain with small molecules offers a potential strategy for controlling necroptosis.
• Understanding MLKL regulation provides insights into therapeutic interventions for diseases involving aberrant cell death.